WO2000025814A3 - Constituant pour un vaccin - Google Patents

Constituant pour un vaccin Download PDF

Info

Publication number
WO2000025814A3
WO2000025814A3 PCT/GB1999/003559 GB9903559W WO0025814A3 WO 2000025814 A3 WO2000025814 A3 WO 2000025814A3 GB 9903559 W GB9903559 W GB 9903559W WO 0025814 A3 WO0025814 A3 WO 0025814A3
Authority
WO
WIPO (PCT)
Prior art keywords
meningococci
component
vaccine against
against serogroup
serogroup
Prior art date
Application number
PCT/GB1999/003559
Other languages
English (en)
Other versions
WO2000025814A2 (fr
Inventor
Bambos Michael Charalambous
Ian Michael Feavers
Original Assignee
Univ London
Nat Inst Of Biolog Standards A
Bambos Michael Charalambous
Ian Michael Feavers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ London, Nat Inst Of Biolog Standards A, Bambos Michael Charalambous, Ian Michael Feavers filed Critical Univ London
Priority to EP99951011A priority Critical patent/EP1124574A2/fr
Priority to JP2000579253A priority patent/JP2002528517A/ja
Publication of WO2000025814A2 publication Critical patent/WO2000025814A2/fr
Publication of WO2000025814A3 publication Critical patent/WO2000025814A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Constituant pour un vaccin contre les méningocoques du sérogroupe B, qui comporte un mimotope d'un lipooligosaccharide de surface d'un méningocoque du sérogroupe B.
PCT/GB1999/003559 1998-10-30 1999-10-27 Constituant pour un vaccin WO2000025814A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP99951011A EP1124574A2 (fr) 1998-10-30 1999-10-27 Constituant pour un vaccin
JP2000579253A JP2002528517A (ja) 1998-10-30 1999-10-27 ワクチン成分

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9823835.5 1998-10-30
GBGB9823835.5A GB9823835D0 (en) 1998-10-30 1998-10-30 Component for vaccine

Publications (2)

Publication Number Publication Date
WO2000025814A2 WO2000025814A2 (fr) 2000-05-11
WO2000025814A3 true WO2000025814A3 (fr) 2000-07-27

Family

ID=10841614

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1999/003559 WO2000025814A2 (fr) 1998-10-30 1999-10-27 Constituant pour un vaccin

Country Status (4)

Country Link
EP (1) EP1124574A2 (fr)
JP (1) JP2002528517A (fr)
GB (1) GB9823835D0 (fr)
WO (1) WO2000025814A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0024200D0 (en) * 2000-10-03 2000-11-15 Smithkline Beecham Sa Component vaccine
GB0106315D0 (en) 2001-03-14 2001-05-02 Ich Productions Ltd Transfection complexes
DE60219215T2 (de) * 2002-10-23 2008-01-03 Centre For Research And Technology Hellas/Intitute Of Agrobiotechnology In.A, Thermi Prionen-bindende peptidsequenzen
GB0718966D0 (en) * 2007-09-28 2007-11-07 Liverpool School Of Tropical M Bacterial vaccine
BR112020017715A2 (pt) * 2018-03-16 2020-12-29 Zoetis Services Llc Vacinas de peptídeo contra interleucina-31
EP4104835A4 (fr) * 2020-02-10 2024-05-01 Juntendo Educational Found Inhibiteur de l'activité du récepteur de la ryanodine de type 2

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997046582A1 (fr) * 1996-06-05 1997-12-11 Peptide Therapeutics Limited Vaccin meningococcique
WO1998008874A1 (fr) * 1996-08-27 1998-03-05 Chiron Corporation Anticorps monoclonaux definissant des epitopes meningococciques b et leurs utilisations dans la preparation de compositions vaccinales

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997046582A1 (fr) * 1996-06-05 1997-12-11 Peptide Therapeutics Limited Vaccin meningococcique
WO1998008874A1 (fr) * 1996-08-27 1998-03-05 Chiron Corporation Anticorps monoclonaux definissant des epitopes meningococciques b et leurs utilisations dans la preparation de compositions vaccinales

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1996, GAO LIHUI HU XUJING ET AL: "Study on the LOS antigenicity of 2 candidate strains for meningococcal vaccine of serogroup B.", XP002133714, Database accession no. PREV199799335486 *
JONES D M: "Meningococcal vaccines [editorial].", JOURNAL OF MEDICAL MICROBIOLOGY, (1993 FEB) 38 (2) 77-8., XP000891214 *
KIEBER-EMMONS THOMAS: "Peptide mimotopes of carbohydrate antigens.", IMMUNOLOGIC RESEARCH JAN., 1998, vol. 17, no. 1-2, January 1998 (1998-01-01), pages 95 - 108, XP000892784, ISSN: 0257-277X *
ROMERO DIAZ J ET AL: "CURRENT STATUS OF MENINGOCOCCAL GROUP B VACCINE CANDIDATES: CAPSULAR OR NONCAPSULAR?", CLINICAL MICROBIOLOGY REVIEWS,US,WASHINGTON, DC, vol. 7, no. 4, 1 October 1994 (1994-10-01), pages 559 - 575, XP002039373, ISSN: 0893-8512 *
ZHONGHUA WEISHENGWUXUE HE MIANYIXUE ZAZHI 1996, vol. 16, no. 6, 1996, pages 405 - 408, ISSN: 0254-5101 *

Also Published As

Publication number Publication date
EP1124574A2 (fr) 2001-08-22
JP2002528517A (ja) 2002-09-03
WO2000025814A2 (fr) 2000-05-11
GB9823835D0 (en) 1998-12-23

Similar Documents

Publication Publication Date Title
BE2011C001I2 (fr)
CA2463289A1 (fr) Systeme de cimentation pour puits de forage
AU2001267198A1 (en) A method for the application of implicit signature schemes
EP1382135A4 (fr) Procedes de suppression d'interferences pour 802.11
AU3089399A (en) Double mutant enterotoxin for use as an adjuvant
AU6659598A (en) Device and method for framing pictures, certificates and the like
MXPA03008856A (es) Metodos para la produccion de lipido a 3-o-desacilado-4¦-monofosforilo (3d-mla).
AU2001237303A1 (en) Polysiloxanes used for hydrophobing
WO2000025814A3 (fr) Constituant pour un vaccin
HK1057115A1 (en) Method of verifying the authenticity of dynamically connectable executable images.
WO2001007408A3 (fr) Nouveau procede de preparation de composes benzoperhydroisoindole
AU2426299A (en) Steam box
HK1037959A1 (en) Cyclophosphamide coated tablets.
HK1048112A1 (en) Process for the preparation of a 3-vinylcephem compound.
AUPP232798A0 (en) Integrated rankine engine
BR0016668B1 (pt) processo para a preparação de n-fosfonometilglicina, processo para a preparação de um composto fosfono, composto fosfono, e, intermediário.
AU1090800A (en) Linker-assisted immunoassay for glyphosate
AU2001277019A1 (en) Pump purge for oil primary
AU2107400A (en) Neisseria meningitidis antigen
AU4727899A (en) A method for diagnosing selected adenocarcinomas
AU6390001A (en) 6,10-dimethyl-5,9-undecadien-2-ol
AU5613400A (en) Method for providing a free connection for an internet appliance
AU2001294545A1 (en) 27877, a novel phospholipase and uses therefor
AU2002226434A1 (en) A method for diagnosing atrophic gastritis
AU2001289671A1 (en) Bridged glycoconjugates

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 579253

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1999951011

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999951011

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09830702

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 1999951011

Country of ref document: EP